News
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth
Zomedica Corp. reports strong financial results for Q4 and FY 2024, with record revenue and growth in Diagnostics segment. Company's focus on accelerated revenue growth in 2025 highlighted -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET
Zomedica Corp. to host conference call on March 13, 2025, to discuss Q4 and FY 2024 financial results. Leading veterinary health company offering innovative solutions -
